Who invested in Esperance Pharmaceuticals?
Esperance Pharmaceuticals's investors include Advantage Capital, Louisiana Technology Innovation Fund, Louisiana Funds and Themelios Ventures.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$20Mraised across 3 rounds since 2010, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by money.msn.comSEC filing: $5.7M sold, first sale May 2011
No investor was named in the report.
Reported by sec.govSEC filing: $9.0M sold, first sale Oct 2006
No investor was named in the report.
Reported by sec.govSEC filing: $9.0M sold, first sale Oct 2006
From the SEC filings it signed: 3 on the team.
On the board, as filediJoseph LovettPeter HoangRoss Barrett
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Esperance Pharmaceuticals's investors include Advantage Capital, Louisiana Technology Innovation Fund, Louisiana Funds and Themelios Ventures.
Esperance Pharmaceuticals has raised $20M across 3 rounds since 2010.
Esperance Pharmaceuticals's most recent round was a Series B of $7.5M in Jun 2011.
Esperance Pharmaceuticals's largest round on record is $9.0M (Venture), in May 2010.
Esperance Pharmaceuticals's first round on record, in Jun 2011, was backed by Advantage Capital, Louisiana Technology Innovation Fund and Louisiana Funds and 1 others.
Esperance Pharmaceuticals's latest named round is a Series B, in Jun 2011.
Esperance Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.